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Abstract 
Purpose: To investigate the interactions between metformin and Yoyo Bitters® including some of its 
constituents in the management of diabetes mellitus. 
Method: Using the generic form of metformin (Glucophage®) tablets, tests such as disintegration time, 
dissolution profile, Fourier transform infrared (FTIR) spectroscopy and in vivo hypoglycaemia tests using 
Wistar albino rat were performed for metformin to investigate its behaviour in the presence and absence 
of Yoyo Bitters and some plant extracts used in its formulation. 
Results: Metformin tablets used met BP specification in terms of pharmaceutical properties. There was 
no significant change in the disintegration properties of the metformin tablets in the presence of Yoyo 
Bitters (p > 0.05) while a significant change occurred in the dissolution profile (p < 0.05). The FTIR 
spectra showed some level of interactions due to disappearance of some spectral peaks. In vivo result 
showed a significant reduction (p < 0.05) in the duration of action of metformin. 
Conclusion: Concomitant administration of metformin and Yoyo Bitters showed interaction that 
appeared antagonistic to the hypoglycaemic effect of metformin both in vitro and in rat models 
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Herb-drug interaction results from the co-
administration of a herbal product and a 
conventional drug. These interactions can be 
synergistic or antagonistic in nature. Herbal-drug 
interactions have also been reported to alter the 
absorption, distribution, metabolism and 
elimination of conventional drugs [1]. 
 
The rational use of herbal medicines is of 
particular importance because the majority of 
these products are self-prescribed and often 
used to treat minor and sometimes chronic 
conditions. However, most patients consuming 
herbal preparations are not aware of the toxic or 
potential adverse effects these preparations may 
produce [2-5] or any form of interactions 
associated with the use of such products when 
co-administered with orthodox medicine [6,7]. 
Some known herb-drug interactions have been 
reported to be negative in nature, such as 
concomitant administration of garlic and warfarin 
which leads to prolonged bleeding [8-10], while 
some interactions may have beneficial effect on 
drug therapy. For example, rhubarb and 
mirabilitum, which are purgatives, have been 
reported to produce more reliable and stronger 
purgative action when used together [11]. 
 
Metformin is a well-known oral hypoglycaemic 
drug used in the management of type 2 diabetes 
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mellitus. Yoyo Bitters® is an herbal tonic widely 
used in Nigeria with claims of detoxification, 
helps to reduce body fat and consequently 
enhances weight loss. Some of its constituents 
includes Aloe vera and Citrus aurantifolia (key 
lime). Aloe vera is claimed to have wound 
healing, anti-microbial, anti-tumour, anti-aging, 
anti-inflammatory, anti-septic, anti-viral and 
antidiabetic properties [12,13]. Citrus aurantifolia 
has been reported to have antioxidant effect [14] 
and used traditionally as a worm expeller, anti-
microbial, anti-cancer, anti-parasitic agents as 
well as for weight loss, colds and arthritis [13]. 
There are undocumented reports by the vendors 
of Yoyo Bitters of its use by some diabetic 
patients that are already on commonly used oral 
hypoglycaemic drugs. They believe that Yoyo 
Bitters improve their well-being without any 
particular justification for this belief except that 
the herbal product is natural and claims to do so. 
This study was carried out to investigate any 
form of interaction between metformin and Yoyo 
Bitters and some of its constituents during 






Metformin powder was a gift sample from 
Springs Nigerian Enterprises, Lagos, Nigeria, 
Hydrochloric acid was obtained from May and 
Baker, England. Citrus aurantifolia (key lime) and 
Aloe vera were obtained from the botanical 
garden of the Faculty of Pharmacy, University of 
Benin. Plant samples were identified and 
authenticated by Dr Joseph Erhabor and voucher 
specimen numbers (UBH_r0282 and 
UBH_x0169a, respectively) were assigned. The 
plant samples were kept in the herbarium of the 
Department of Plant Biology and Biotechnology, 
University of Benin, Nigeria. Glucophage® tablets 
and Yoyo Bitters® were purchased from a 
Pharmacy in Benin City, Nigeria. Their labelled 
information are shown in Table 1. 
 
Preliminary physicochemical evaluation of 
tablets 
 
Metformin (Glucophage®) tablets containing 500 
mg of metformin hydrochloride were subjected to 
some preliminary physicochemical evaluations 
such as physical examination, organoleptic 
properties, weight uniformity, friability and 





Twenty (20) metformin tablets were randomly 
selected and weighed (Mettler Toledo, 
Switzerland) and the mean weight was 
computed. The percentage deviation of each 





Ten (10) tablets were randomly selected, dusted 
and weighed together and then placed in the 
Roche friabilator and operated for 4 min at 25 
rpm. The tablets were de-dusted and reweighed 




Using a motorized tablet hardness tester 
(Campbell Electronics, Model HT-30/50, India), 
the hardness of each of ten tablets was 
determined by diametrial compression of the 





Disintegration test  
 
The time taken for six metformin tablets to 
disintegrate in 500 mL distilled water at 37 ± 1.0 
°C and for the particles to pass through the mesh 
of the BP disintegration tester (MK IV, Manesty 
Machines, UK) was determined. The mean or 
average time was calculated. The test was 
repeated using 500 mL of distilled water-Yoyo 
Bitters mixture. The mixture was prepared by 
making up 30 mL of Yoyo Bitters to 500 mL with 
distilled water. This 30 mL is the recommended 
adult dose based on information obtained from 




The dissolution test of metformin tablets was 
carried out using the BP paddle method. 
 














Glucophage Y00060 04-6233 02/2015 01/2020 Nigeria 
Yoyo Bitters NBR 1520 A7-10552 06/2015 07/2017 Nigeria 
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A dissolution apparatus (Caleva ST7, UK) 
containing 500 mL solution of phosphate buffer 
pH 6.8 maintained at 37 ± 1.0 C with a paddle 
speed of 50 rpm was used. A tablet selected at 
random was placed in the dissolution vessel and 
operated over a period of 60 min. A 5 mL sample 
was withdrawn from the dissolution fluid at 
specific time intervals and replaced with an 
equivalent volume of fresh fluid maintained at 
same temperature (37  1.0 C) in order to 
maintain sink condition. The withdrawn samples 
were filtered and subjected to UV-
spectrophotometric analysis at max of 232 nm 
(T70, PG Instruments Ltd). The amount and the 
percentage of drug released at each time interval 
was calculated by extrapolation from the 
standard calibration plot obtained from pure 
metformin powder.  
 
The test was repeated using 500 mL of 
phosphate buffer containing 30 mL of Yoyo 
Bitters. 
 
Absorbance interference study 
 
Metformin alone  
 
A quantity of metformin powder equivalent to 100 
mg was dissolved in 50 mL of 0.1 N HCl solution 
in a 100 mL volumetric flask. The volume was 
made up to 100 mL with more 0.1 N HCl solution 
to obtain a metformin stock solution of 1.0 
mg/mL. Gradient metformin standard 
concentrations ranging from 2.0 to 10 μg/mL 
were prepared from the stock solution using 0.1 
N HCl solution and subjected to ultra-violet 
spectrophotometric analysis at 232 nm. Triplicate 
readings were taken and the mean of the 
respective absorbance was calculated. A plot of 
absorbance vs metformin concentration was 
drawn. 
 
Metformin plus either Yoyo Bitters, Aloe vera 
or Citrus aurantifolia 
 
The Yoyo Bitters was first of all dried in a 
porcelain dish over a hot water bath until a 1 g 
dried residue was obtained. Metformin-Yoyo 
Bitters stock solution was then prepared by 
dissolving 100 mg of metformin powder and 1 g 
of the dried Yoyo Bitters residue in 50 mL of 0.1 
N HCl solution and made up to 100 mL. Serial 
dilutions of the metformin-Yoyo Bitters mixture 
ranging from 2.0 to 10 µg/mL of metformin were 
prepared using 0.1 N HCl as diluent.  
 
For Aloe vera, the bark of the leaves was 
removed with a kitchen knife and the juice 
extracted after blending. The juice was dried in a 
porcelain dish over a thermostated water bath. 
One gram of the dried juice residue was diluted 
with 0.1 N HCl solution to 100 mL, left overnight 
and filtered. The filtrate was then used to serially 
dilute metformin stock solution (1.0 mg/mL 0.1 N 
HCl solution) into a range of concentrations (2.0 
to 10 µg/mL of metformin). The dilutions were 
shaken intermittently for 30 min and thereafter 
left to stand for another 30 min. 
 
Similarly, juice from lime fruits was extracted 
using a juice extractor. The extracted juice was 
dried in a porcelain dish over a thermostated 
water bath and 1 g of the dried product was 
added to 100 mg of metformin powder and made 
up to 100 mL with 0.1 N HCl solution to give a 
metformin-Citrus aurantifolia stock solution.  The 
stock solution was left to stand for 1 h with 
intermittent shaking and then serially diluted with 
more 0.1 N HCl solution to a range of 
concentrations from 2.0 to 10 µg/mL of 
metformin. 
 
All the samples prepared and their respective 
dilutions were analysed spectrophotometrically in 
triplicates at 232 nm and their mean values 
plotted against their concentrations to obtain a 




Dried Yoyo Bitters powder, pure metformin 
powder and their admixture were subjected to 
FTIR analysis using the potassium bromide 
tablet method (FTIR-4100 Spectrophotometer, 
Shimadzu Co. Japan). Five milligram powder 
sample was blended with dried potassium 
bromide to give a 200 mg weight powder. The 
powder was compressed using a Sigma 
potassium bromide press into a tablet, and then 
placed in the sample compartment of the 
spectrophotometer and scanned at a range of 




Healthy Wistar Albino rats of both sex, with mean 
weight of 225 g were purchased from the 
Department of Biochemistry, University of Benin 
and allowed to acclimatize for two weeks in the 
animal house of the Department of 
Pharmacology and Toxicology, Faculty of 
Pharmacy, University of Benin, Benin City. 
Ethical approval for the study was obtained from 
the Ethical Committee on the Use of Animals for 
Experiments, Faculty of Pharmacy, University of 
Benin, Benin City, Nigeria. The animals were 
treated according to the principle established for 
the care and use of laboratory animals [16]. 
Diabetes was induced using a single dose of 150 
mg/kg streptozotocin, administered intraperito-
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neally in 0.05 M citrate buffer solution pH 4.5 
[17]. The animals were left for 72 h and in order 
to prevent hypoglycemic shock within the first 24 
h, the animals were administered with 10 % 
glucose solution orally. After 72 h, experimental 
diabetes was confirmed in the rats using the 
AccuChek Active glucometer (Roche, USA) and 
fasting blood glucose level greater than 200 
mg/dL (11.1 mmol/L) was taken as being diabetic 
[18]. 
 
The diabetic animals fasted overnight were 
divided into four groups (A-D) of five animals 
each. They had free access to water prior to the 
experiment. Using an orogastric syringe, groups 
A and B rats were orally given an aqueous stock 
solution of metformin at a dose of 100 mg per kg 
body weight. Thereafter, a dose of 15.49 kg/mL 
of Yoyo Bitters (a median oral dose) was given to 
groups B and C rats [19]. The last group of rats 
(control) was given 10 mL of distilled water. 
 
Blood samples were obtained from the animals 
using the tail snipping method over a period of 5 
h following a single drug administration for all the 
groups of animals. Blood glucose level was 
determined immediately after sampling using the 
glucometer and expressed at a percentage of the 




Inferential statistical evaluation was done using 
GraphPad InStat software version 3.10. One-way 
analysis of variance (ANOVA) was determined at 
a p < 0.05 level of significance using Dunnett’s 




Preliminary tablet evaluation 
 
Results from the preliminary evaluations carried 
out on the metformin (Glucophage®) tablets are 
presented in Table 2. The tablets were elegant in 
their organoleptic appeal and showed a mean 
weight variation, percentage friability and mean 
crushing strength values that meets the BP 
specifications with regards to these parameters 
[15]. 
 
Table 2: Some physicochemical properties of 
metformin (Glucophage®) tablets (mean ± SD) 
 
Tablet property Result 
Colour White 
Surface texture Smooth 
Taste Slightly bitter 
Inscriptions GL 500 
Mean weight (mg) 530 ± 0.007 
Friability (%) 0.25 




Disintegration and dissolution  
 
The results from the interaction studies on the 
effect of Yoyo Bitters on the disintegration time 
and dissolution profile of metformin tablets are 
shown in Table 3 and Figure 1. The 
disintegration times of the metformin tablets in 
distilled water and in the presence of Yoyo 
Bitters was the same (Table 3). The dissolution 
profile of the tablets in phosphate buffer was not 
the same as in the phosphate buffer-Yoyo Bitters 
mixture (Figure 1) with different metformin 
release pattern and maximum drug release. The 
tablets showed a maximum metformin release 
(m∞) of 73.6 % within 60 min with phosphate 
buffer as the dissolution medium as against a 
47.5 % release in the phosphate buffer-Yoyo 
Bitters mixture. The tablets achieved 50 and 70 
% release in 46 and 55 min respectively in 
phosphate buffer. 
 
Figure 1: Dissolution profiles of metformin tablets in 
the absence of Yoyo Bitters () and presence of Yoyo 
Bitters () 
Table 3: Disintegration and dissolution release parameters of metformin (Glucophage®) tablets in the absence or 
presence of Yoyo Bitters 
 
Parameter Absence of Yoyo bitters Presence of Yoyo bitters 
Disintegration time (min) 1.56±0.82 1.56±0.66 
Dissolution 
parameters 
m∞ (%) 73.6±0.22 47.5±0.48 
t50% (min) 46±0.36 - 
t70% (min) 55±0.44 - 
Values are mean ± standard deviation 
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A comparison of the absorbance of the various 
dilutions of the stock solutions of metformin and 
the mixtures of metformin with either Yoyo 
Bitters, Aloe vera or Citrus aurantifolia is shown 
in Figure 2. The extract altered the UV 
absorbance of metformin in a non-specific 
manner. Metformin alone showed a linear 
increase in absorbance that was proportional to 
the concentration from 2 to 8 µg/mL, while the 
presence of Yoyo Bitters showed an initial 
decline in absorbance at 2 and 4 µg/mL followed 
by a much higher increase in absorbance at 6 
and 8 µg/mL. Citrus aurantifolia on the other 
hand gave a steady concentration based decline 
in metformin absorbance while Aloe vera 
resulted in total disappearance in metformin 
absorbance. Values obtained at 10 µg/mL did not 




Spectra from the FTIR analysis are shown in 
Figure 3. The spectrum obtained from metformin 
(Figure 3 (a)) exhibits numerous peaks. A 
comparison of the spectra of Yoyo Bitters (Figure 
3 (b)) and the admixture of metformin and Yoyo 
Bitters (Figure 3 (c)) with that of metformin shows 
a significant reduction in the number of peaks of 




Figure 2: A comparison of the absorbances of the serial dilutions of stock solutions of metformin (MET) and a 
mixture of metformin with either Yoyo Bitters (YB), Aloe vera (AV) or Citrus aurantifolia (CA) 
 
 
Figure 3: FTIR spectra of metformin alone (a), Yoyo Bitters (b) and the admixture of metformin and Yoyo Bitters 
(c) 
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In vivo interaction 
 
Results from the in vivo interaction study 
between metformin and Yoyo Bitters in 
streptozotocin-induced hyperglycaemic rats are 
shown in Figure 4. There was a significant 
reduction in hyperglycaemia (p < 0.05) in all the 
metformin and Yoyo Bitters treated groups after 
a single oral administration of the drugs. 
However, groups treated with the mixture of 
metformin and Yoyo Bitters had their 
hypoglycaemia reversed after 3 h while 
metformin alone continued to show reduction in 
blood glucose up to 5 h of the study. Yoyo Bitters 
alone showed reduction in blood glucose which 
was reversed after 4 h of study. 
 
 
Figure 4: Percentage blood glucose lowering in 
diabetic animals administered metformin alone (), 
Yoyo Bitters (), a mixture of metformin and Yoyo 




Herb-drug interactions are usually not easily 
detectable at the initial stage of physical blending 
of the herbs and drugs. Hence there appeared to 
be no significant change to the physical 
parameters of metformin tablets [6]. Further 
investigations of dissolution studies showed a 
difference in the dissolution profiles of metformin 
tablets alone and in the presence of Yoyo-bitters. 
There was evidence of an initial increased rate of 
dissolution in the presence of Yoyo Bitters but 
with time the rate of dissolution was reduced.  
 
The absorbance results show that this initial 
increase may be as a result of interference by 
Yoyo Bitters since at 6 to 8 µg/mL, there was a 
remarkable increase in the absorbance of the 
mixtures. The rate of dissolution in distilled water 
increased steadily and 73.6 % of metformin was 
dissolved in 1 h while in the presence of Yoyo 
Bitters, only 47.5 % of metformin was dissolved 
in the medium suggesting that the presence of 
Yoyo Bitters affected the dissolution profile of 
metformin tablets [7]. This would likely be due to 
saturation of the dissolution medium by the 
components of Yoyo bitters which results in 
slowing down the dissolution rate of metformin 
from tablets. The absorbance test showed an 
increase in the absorbance of metformin at its 
wavelength in the presence of Yoyo Bitters and 
some of its constituents. This is probably due to 
the presence of components that have close or 
same wavelength of absorbance as metformin.  
The presence of Citrus aurantifolia showed that 
there was no significant change in the 
absorbance of metformin while in the presence of 
Aloe vera, there was no noticeable absorbance 
reading for metformin showing that A. vera 
interfered significantly with metformin, so that its 
presence could not be detected in the mixture by 
the UV-spectrophotometer. While the cause of 
this interference is not very clear, it may be 
helpful to investigate further based on the 
components of A. vera plant. It is also likely that 
the A. vera constituents of Yoyo Bitters may have 
been responsible for the significant level of 
observable interactions. 
 
In vivo hypoglycaemic activity which was 
performed on rats showed a reduction in glucose 
levels from the first hour to the third hour for all 
the treated groups (A to C), but at the fifth hour, 
only metformin continued to reduce the blood 
glucose levels. The blood glucose lowering 
activity of Yoyo Bitters was not sustained after 
the third hour while that of metformin was steady 
and sustained even till the fifth hour [19]. The 
mixture resulted in early reversal of 
hypoglycaemia noticed at the fourth hour. This 
reversal infer that although both agents caused 
hypoglycaemia, the interaction showed 
antagonism on the hypoglycaemic action of the 
metformin by Yoyo bitters. The reason for the 
reduction in duration of action of metformin might 
be explained from the FTIR results where the 
components of Yoyo biters mask the functional 
group responsible for the prolonged action of 
metformin leading to reduced duration of action 
of the metformin as seen in the study. Another 
possibility is the metformin/Yoyo bitters 
competitive binding to receptor site for drug 
action due to similarity in the nature of some 
constituents. There is the possibility of 
constituents of Yoyo bitters displacing metformin 
and thereby leading to a reduction and their 




Yoyo Bitters exerts blood glucose-lowering 
activity in streptozotocin-induced diabetic rats. 
Furthermore, when given concomitantly with 
metformin, it results in the reduction in the 
hypoglycaemic activity of metformin. Although 
there was no change in the disintegration time, 
there was evident interaction in the dissolution 
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profile of the metformin tablets. Furthermore, 
Aloe vera, which is a constituent of Yoyo Bitters, 
may be responsible for the interaction seen. The 
concomitant administration of metformin and 
Yoyo Bitters leads to interaction that is 
antagonistic to the hypoglycaemic effect of 
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